Cognext Diagnostics LLC

Baltimore, MD

UEI
L393CE1KTBR9
CAGE
85B91
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
3904 Cloverhill Rd, Baltimore, MD 21218, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Plasma assays for NPTX2 in alzheimer's disease R43AG074773 National Institute on Aging (NIH) $1,499,997
A novel biological marker and elisa assay for determination of cognitive resilience in alzheimer's disease R43AG064998 National Institute on Aging (NIH) $328,557

Quick answers

Is Cognext Diagnostics LLC registered in SAM.gov?

Yes. Cognext Diagnostics LLC's SAM.gov registration is active through February 18, 2027.

What is Cognext Diagnostics LLC's most recent federal award?

Cognext Diagnostics LLC's most recent federal grant award is Plasma assays for NPTX2 in alzheimer's disease (R43AG074773), from National Institute on Aging (NIH), on September 1, 2021.

On GovTribe

See Cognext Diagnostics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login